Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 99.93%
August 31, 2026 99.93%
July 31, 2026 99.93%
June 30, 2026 99.93%
May 31, 2026 99.93%
April 30, 2026 99.93%
March 31, 2026 99.93%
February 28, 2026 99.93%
January 31, 2026 99.93%
December 31, 2025 99.93%
November 30, 2025 99.93%
October 31, 2025 99.93%
September 30, 2025 99.93%
August 31, 2025 99.93%
July 31, 2025 99.93%
June 30, 2025 99.93%
May 31, 2025 99.93%
April 30, 2025 99.91%
March 31, 2025 99.91%
February 28, 2025 99.91%
January 31, 2025 99.68%
December 31, 2024 99.68%
November 30, 2024 99.68%
October 31, 2024 99.68%
September 30, 2024 99.68%
Date Value
August 31, 2024 99.68%
July 31, 2024 99.68%
June 30, 2024 99.09%
May 31, 2024 99.09%
April 30, 2024 99.09%
March 31, 2024 99.09%
February 29, 2024 99.09%
January 31, 2024 99.09%
December 31, 2023 99.09%
November 30, 2023 99.09%
October 31, 2023 99.09%
September 30, 2023 99.09%
August 31, 2023 99.09%
July 31, 2023 99.09%
June 30, 2023 99.09%
May 31, 2023 99.09%
April 30, 2023 99.09%
March 31, 2023 99.09%
February 28, 2023 99.09%
January 31, 2023 99.09%
December 31, 2022 99.09%
November 30, 2022 99.09%
October 31, 2022 99.09%
September 30, 2022 99.09%
August 31, 2022 99.09%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Cochlear Ltd. 71.44%
ImpediMed Ltd. 98.50%
Nanosonics Ltd. 72.61%
Somnomed Ltd. 94.01%
Nova Eye Medical Ltd. 99.91%